Fei Xu

Affiliated Hospital of Shandong University of Traditional Chinese Medicine, China

Title: Icariside II induced ferroptosis to suppress the progression of NSCLC through activation of the mitochondrial dysfunction

---

Biography

Professor Fei Xu received his PhD in Chinese and Western Integrative Medicine from Fudan University, China. Professor Fei’s major interests are Antitumor effects of TCM from Tumor immunology, Metabolism in tumor and immunology and Mechanical signaling in tumor and immunology. Her strategy involves research programs in basic biology and in clinical medicine. Her group is currently developing and testing natural small molecular compounds isolated from Chinese Herbs against NSCLC. A number of these small-molecule compounds have been experimentally verified and her group aim to progress these drugs to clinical trials.

Abstract